Dimensional Fund Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-29,448
| Closed | -$279K | – | 3488 |
|
|
2022
Q1 | $279K | Sell |
29,448
-10,765
| -27% | -$101K | ﹤0.01% | 3259 |
|
|
2021
Q4 | $464K | Sell |
40,213
-2,200
| -5% | -$24.5K | ﹤0.01% | 3183 |
|
|
2021
Q3 | $405K | Sell |
42,413
-4,288
| -9% | -$43.9K | ﹤0.01% | 3225 |
|
|
2021
Q2 | $450K | Sell |
46,701
-527
| -1% | -$5.14K | ﹤0.01% | 3182 |
|
|
2021
Q1 | $467K | Sell |
47,228
-63,994
| -58% | -$991K | ﹤0.01% | 3157 |
|
|
2020
Q4 | $2.57M | Sell |
111,222
-554,104
| -83% | -$11.3M | ﹤0.01% | 2738 |
|
|
2020
Q3 | $9.39M | Sell |
665,326
-27,670
| -4% | -$403K | ﹤0.01% | 2222 |
|
|
2020
Q2 | $10.5M | Sell |
692,996
-68,807
| -9% | -$838K | ﹤0.01% | 2186 |
|
|
2020
Q1 | $7.04M | Buy |
761,803
+42,907
| +6% | +$408K | ﹤0.01% | 2272 |
|
|
2019
Q4 | $7M | Buy |
718,896
+279,441
| +64% | +$2.56M | ﹤0.01% | 2495 |
|
|
2019
Q3 | $3.52M | Buy |
439,455
+304,573
| +226% | +$3.31M | ﹤0.01% | 2712 |
|
|
2019
Q2 | $1.68M | Sell |
134,882
-296,635
| -69% | -$3.76M | ﹤0.01% | 2942 |
|
|
2019
Q1 | $5.87M | Sell |
431,517
-666,566
| -61% | -$8.14M | ﹤0.01% | 2597 |
|
|
2018
Q4 | $10.5M | Buy |
1,098,083
+866,793
| +375% | +$9.53M | ﹤0.01% | 2316 |
|
|
2018
Q3 | $2.8M | Buy |
+231,290
| New | +$3.23M | ﹤0.01% | 2845 |
|
|
2018
Q1 | – | Sell |
-347,563
| Closed | -$5M | – | 3350 |
|
|
2017
Q4 | $5M | Sell |
347,563
-3,526
| -1% | -$48.4K | ﹤0.01% | 2619 |
|
|
2017
Q3 | $5.29M | Sell |
351,089
-5,894
| -2% | -$78K | ﹤0.01% | 2580 |
|
|
2017
Q2 | $3.6M | Sell |
356,983
-3,165
| -0.9% | -$25.5K | ﹤0.01% | 2698 |
|
|
2017
Q1 | $2.57M | Buy |
360,148
+72,674
| +25% | +$459K | ﹤0.01% | 2782 |
|
|
2016
Q4 | $1.43M | Sell |
287,474
-162,602
| -36% | -$1.13M | ﹤0.01% | 2894 |
|
|
2016
Q3 | $3.33M | Buy |
450,076
+14,340
| +3% | +$96.9K | ﹤0.01% | 2637 |
|
|
2016
Q2 | $2.38M | Buy |
435,736
+423,260
| +3,393% | +$2.96M | ﹤0.01% | 2726 |
|
|
2016
Q1 | $105K | Buy |
+12,476
| New | +$88.4K | ﹤0.01% | 3231 |
|
|
2015
Q1 | – | Sell |
-8,090
| Closed | -$67K | – | 3354 |
|
|
2014
Q4 | $67K | Hold |
8,090
| – | – | ﹤0.01% | 3350 |
|
|
2014
Q3 | $48K | Hold |
8,090
| – | – | ﹤0.01% | 3399 |
|
|
2014
Q2 | $27K | Sell |
8,090
-10,400
| -56% | -$24.4K | ﹤0.01% | 3479 |
|
|
2014
Q1 | $38K | Sell |
18,490
-21,200
| -53% | -$53K | ﹤0.01% | 3473 |
|
|
2013
Q4 | $93K | Sell |
39,690
-10,500
| -21% | -$23K | ﹤0.01% | 3358 |
|
|
2013
Q3 | $116K | Buy |
50,190
+40,889
| +440% | +$103K | ﹤0.01% | 3374 |
|
|
2013
Q2 | $22K | Buy |
+9,301
| New | +$28.6K | ﹤0.01% | 3489 |
|
Other funds holding FOLD
PA
ACA
RG
Dimensional Fund Advisors's FOLD Position: Q2 2022 in Review
Dimensional Fund Advisors sold out of Amicus Therapeutics (FOLD) in Q2 2022, closing a stake of 29,448 shares — an estimated $279K sold.
Dimensional Fund Advisors first reported a position in FOLD in Q2 2013 and held it in 30 quarters. The position peaked at $10.5M in Q4 2018. 212 funds tracked by Wall St. Rank hold FOLD as of Q2 2022.
- Dimensional Fund Advisors reported no remaining Amicus Therapeutics position as of Q2 2022 after selling out during the quarter.
- Dimensional Fund Advisors sold 29,448 Amicus Therapeutics shares in Q2 2022, an estimated $279K.
- Dimensional Fund Advisors first reported a position in Amicus Therapeutics in Q2 2013 and held it in 30 quarters.
- Dimensional Fund Advisors's Amicus Therapeutics position peaked at $10.5M in Q4 2018.
- 212 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2022.
Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.